Cyclotheonamide A
Also known as: CTN‑A, Cyclotheonamide A
Source Cyclotheonamide A at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Cyclotheonamide A is a cyclic peptide isolated from marine sponges that acts as a high‑affinity thrombin inhibitor. It is used primarily as a biochemical tool and has not progressed to clinical development.
Mechanism of Action
potent inhibition of serine proteases, particularly thrombin, leading to antithrombotic activity
Routes of Administration
Goals & Uses
- antithrombotic therapyCardiovascularLow
Contraindications
No contraindications recorded yet.
Adverse Effects
No adverse effects recorded yet.
Drug Interactions
No drug interactions recorded yet.
Population Constraints
No population constraints recorded yet.
Regulatory Status
No regulatory status recorded yet.
Evidence & Sources
No sources recorded yet.
Frequently Asked Questions
What is Cyclotheonamide A?
Cyclotheonamide A is a cyclic peptide isolated from marine sponges that acts as a high‑affinity thrombin inhibitor. It is used primarily as a biochemical tool and has not progressed to clinical development.
What is Cyclotheonamide A used for?
Cyclotheonamide A is educationally associated with: antithrombotic therapy. Educational only — not medical advice.
How is Cyclotheonamide A administered?
Recorded routes of administration: Intravenous.